FDA approves irinotecan as first-line therapy for colorectal cancer

被引:0
|
作者
不详
机构
来源
ONCOLOGY-NEW YORK | 2000年 / 14卷 / 05期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:652 / +
页数:2
相关论文
共 50 条
  • [31] Metastatic colorectal cancer: irinotecan plus infusional, bolus or oral fluoropyrimidines as first-line treatment
    Kerr, D. J.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (05): : 250 - 251
  • [32] Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study
    J Feliu
    A Salud
    P Escudero
    L López-Gómez
    C Pericay
    C Castañón
    M R López de Tejada
    J M Rodríguez-García
    M P Martínez
    M Sanz Martín
    J J Sánchez
    M González Barón
    British Journal of Cancer, 2004, 90 : 1502 - 1507
  • [33] Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal cancer
    Jungic, Sasa
    Tubic, Biljana
    Gajanin, Radoslav
    Gojkovic, Zdenka
    Rakita, Ivanka
    VOJNOSANITETSKI PREGLED, 2017, 74 (03) : 249 - 255
  • [34] Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer
    Garcia-Alfonso, P.
    Munoz-Martin, A. J.
    Alvarez-Suarez, S.
    Jerez-Gilarranz, Y.
    Riesco-Martinez, M.
    Khosravi, P.
    Martin, M.
    BRITISH JOURNAL OF CANCER, 2010, 103 (10) : 1524 - 1528
  • [35] An update on treatment advances for the first-line therapy of metastatic colorectal cancer
    Lee, James J.
    Chu, Edward
    CANCER JOURNAL, 2007, 13 (05): : 276 - 281
  • [36] Oxaliplatin in colorectal cancer: New data in first-line and adjuvant therapy
    Goldberg, RM
    Saltz, L
    Grem, JL
    Lenz, HJ
    ONKOLOGIE, 2002, 25 : 1 - 11
  • [37] FOLFOX plus cetuximab in first-line therapy of advanced colorectal cancer
    Ehrenberg, Roland
    Halama, Niels
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [38] Maintenance Therapy for First-Line Metastatic Colorectal Cancer: Activity and Sustainability
    Strickler, John H.
    Hurwitz, Herbert I.
    ONCOLOGIST, 2012, 17 (01): : 9 - 10
  • [39] Which strategy after first-line therapy in advanced colorectal cancer?
    Andrea, Coinu
    Fausto, Petrelli
    Francesca, Borgonovo Karen
    Mary, Cabiddu
    Mara, Ghilardi
    Veronica, Lonati
    Sandro, Barni
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (27) : 8921 - 8927
  • [40] Which strategy after first-line therapy in advanced colorectal cancer?
    Coinu Andrea
    Petrelli Fausto
    Borgonovo Karen Francesca
    Cabiddu Mary
    Ghilardi Mara
    Lonati Veronica
    Barni Sandro
    World Journal of Gastroenterology, 2014, (27) : 8921 - 8927